Cargando…
Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Its therapy has not significantly improved during the past four decades despite intense research efforts. New molecularly targeted therapies are in great need. The proto-oncogene c-Myc (MYC) is an attractive targ...
Autores principales: | Zhou, Hao, Liu, Wei, Zhou, Yongming, Hong, Zhenya, Ni, Jian, Zhang, Xiaoping, Li, Ziping, Li, Mengyuan, He, Wenjuan, Zhang, Donghua, Chen, Xuexing, Zhu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576903/ https://www.ncbi.nlm.nih.gov/pubmed/34753494 http://dx.doi.org/10.1186/s13046-021-02145-9 |
Ejemplares similares
-
microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway
por: Chen, Lijuan, et al.
Publicado: (2021) -
The MYC-YBX1 Circuit in Maintaining Stem-like Vincristine-Resistant Cells in Rhabdomyosarcoma
por: Fritzke, Madeline, et al.
Publicado: (2023) -
Depleting long noncoding RNA HOTAIR attenuates chronic myelocytic leukemia progression by binding to DNA methyltransferase 1 and inhibiting PTEN gene promoter methylation
por: Song, Haiping, et al.
Publicado: (2021) -
DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation
por: Li, Mengyuan, et al.
Publicado: (2022) -
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)